Deregulating GMOs in the UK
By GMWatch,
GMWatch
| 01. 19. 2022
A new analysis by A Bigger Conversation suggests that, in its haste to deregulate agricultural gene technologies, the UK government is “choosing to get it wrong” by ignoring expertise from all sides.
The analysis highlights multiple themes missed by the Department for Environment, Food and Rural Affairs’ (DEFRA) official analysis of responses to its 2021 public consultation on the regulation of genetic technologies. It shows that DEFRA's analysis was inadequate and divisive and failed to take account of public opinion.
The DEFRA public consultation on the regulation of genetic technologies was launched in January 2021 and the department’s report on its findings followed in September. At the same time the government announced that it would immediately begin a process of deregulating gene editing in England by:
* Using existing powers under the Environmental Protection Act 1990 to change the law in order to make applications for field trials for plants that have been produced by new genetic technologies simpler and less costly.
* Amending the current definition of a GMO in English law so that organisms produced by new genetic...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
